Acamprosate

Campral, maagsapresistente tabletten 333 mg

Maagsapresistente tabletNetherlandsAuthorisedAuthorised 6 May 2026

In other countries

The same active substances on other registers, the same brand first.

CampralBrazil · Merck S/ASame brand
CampralCanada · 333 MG · Tablet (Delayed-Release) · Mylan Pharmaceuticals UlcSame brand
CAMPRAL 333 mg COMPRIMIDOS RECUBIERTOSSpain · 333 mg · comprimido recubierto · Merck SanteSame brand
CampralItaly · Compressa gastroresistente · Bruno Farmaceutici S.P.A.Same brand
Campral®Serbia · 333mg · gastrorezistentna tableta · Merck D.O.O. BeogradSame brand
Campral®Serbia · 333mg · gastrorezistentna tableta · Merck D.O.O. BeogradSame brand
CampralUnited States · 333MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet, delayed release · Forest LabsSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Acamprosate

Campral, maagsapresistente tabletten 333 mg

Maagsapresistente tabletNetherlandsAuthorisedAuthorised 6 May 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Acamprosate CalciumUnited States · 333MG · tablet, delayed release · Glenmark Pharms LTD

ALGLUTOL 333 mg Delayed-Release TabletsTaiwan · 腸溶錠 · 美時化學製藥股份有限公司

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Acamprosate
Dosage form: Maagsapresistente tablet
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 6 May 2026
Registration: 136724//18220
Marketing authorisation holder: Originalis B.V.
ATC code: N07BB03
Group: Nervous system
Procedure: National (RVG)
Supply: Uitsluitend recept

Campral, maagsapresistente tabletten 333 mgAcamprosate · Maagsapresistente tabletNetherlands